TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314606. A total of 24 filers reported holding TITAN PHARMACEUTICALS INC DE in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $156 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newbridge Financial Services Group, Inc. | 2 | $1 | 0.00% |
| Westside Investment Management, Inc. | 4 | $2 | 0.00% |
| Global Wealth Strategies & Associates | 40 | $19 | 0.00% |
| Cape Investment Advisory, Inc. | 1 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 157 | $73 | 0.00% |
| Nemes Rush Group LLC | 1 | $1 | 0.00% |
| Renaissance Technologies | 135,710 | $64 | 0.00% |
| VANGUARD GROUP INC | 82,051 | $38,892 | 0.00% |
| UBS Group AG | 4 | $2 | 0.00% |
| OSAIC HOLDINGS, INC. | 50 | $22 | 0.00% |